Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Epidemiology and Infection|January 20, 2017
Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013C Brouard, J Pillonel, P Sogni, et al.
Vox Sanguinis|June 23, 2011
Deferral from donating blood of men who have sex with men: impact on the risk of HIV transmission by transfusion in FranceJ Pillonel, V Heraud-Bousquet, B Pelletier, et al.
Revue D'Epidemiologie Et De Sante Publique|February 25, 2016
Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 surveyL Weill-Barillet, J Pillonel, C Semaille, et al.
AIDS Care|April 25, 2007
Differential improvement in survival among patients with AIDS after the introduction of HAARTC Couzigou, C Semaille, Y Le Strat, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2009
Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008Caroline Semaille, F Cazein, F Lot, et al.
Epidemiology and Infection|December 23, 2016
Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveysL Leon, S Kasereka, F Barin, et al.
Transfusion|August 5, 2000
GB virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factorsF Bouchardeau, S Laperche, J Pillonel, et al.
Vox Sanguinis|December 9, 2000
Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donorsM H Elghouzzi, F Bouchardeau, J Pillonel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 25, 2012
[Factsheets: support in the analysis of recipients' adverse reactions]A Bazin, C Trophilme, J-Y Py, et al.
Pageof 4